Less and less of the research presented at a prominent cancer conference is supported by the National Institutes of Health, a development that some of the country’s top scientists see as a worrisome trend.
By Nsikan Akpan, Laura Santhanam
The White House’s full budget request for 2018 seeks sharp cuts to cancer research, climate science and children’s health insurance.
By Nsikan Akpan
Biomedical scientists are struggling to reproduce the work of others. A new book from NPR's Richard Harris explores what to do about it.
As proposed cuts loom, new research digs into the return on investment for public funding of the National Institutes of Health.
By Ike Swetlitz, STAT
On Tuesday, scientists unveiled a five-organ female reproductive system on a chip small enough to hold in your hand, and showed that it could simulate a 28-day menstrual cycle.
In Congress, lawmakers are close to passing a major bill that would increase funding for the FDA, the NIH and the effort to fight opioid abuse. The measure would also introduce more flexible standards for drug approvals, reducing the need…
By Associated Press
The House plans to vote Wednesday on a $6.3 billion bill aimed at speeding federal approval of drugs and medical devices and boosting biomedical research.
By Associated Press
The U.S. National Institutes of Health announced the study Tuesday, saying researchers will enroll participants starting in the first trimester and compare the birth outcomes of those who become infected with Zika and those who don't.
Research on a genetic engineering technique that allows scientists to quickly modify entire populations of organisms should continue in the laboratory — and potentially in the field, an expert panel said Wednesday.
By PBS NewsHour
Weeks ago, hardly anyone in the U.S. knew what the Zika virus was. Now the mosquito-borne illness is raising serious fears, especially for pregnant women. Judy Woodruff talks to Dr. Anthony Fauci of the National Institutes of Health about the…
Support Provided By: Learn more
Educate your inbox
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.